Sesterhenn IA - Search Results

1

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C. Hsing AW, et al. Among authors: sesterhenn ia. Cancer Res. 2000 Sep 15;60(18):5111-6. Cancer Res. 2000. PMID: 11016637

2

Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.

Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C. Hsing AW, et al. Among authors: sesterhenn ia. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):337-41. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927493

3

Body size and prostate cancer: a population-based case-control study in China.

Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J, Xie T, Gao YT. Hsing AW, et al. Among authors: sesterhenn ia. Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1335-41. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11142419

4

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW. Chokkalingam AP, et al. Among authors: sesterhenn ia. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352850

5

Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China.

Lacey JV Jr, Deng J, Dosemeci M, Gao YT, Mostofi FK, Sesterhenn IA, Xie T, Hsing AW. Lacey JV Jr, et al. Among authors: sesterhenn ia. Int J Epidemiol. 2001 Apr;30(2):341-9. doi: 10.1093/ije/30.2.341. Int J Epidemiol. 2001. PMID: 11369740

6

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.

Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Chokkalingam AP, et al. Among authors: sesterhenn ia. Cancer Res. 2001 Jun 1;61(11):4333-6. Cancer Res. 2001. PMID: 11389055

7

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.

Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK. Hsing AW, et al. Among authors: sesterhenn ia. Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1077-82. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11588134

8

Risk of prostate cancer and family history of cancer: a population-based study in China.

Bai Y, Gao YT, Deng J, Sesterhenn IA, Fraumeni JF, Hsing AW. Bai Y, et al. Among authors: sesterhenn ia. Prostate Cancer Prostatic Dis. 2005;8(1):60-5. doi: 10.1038/sj.pcan.4500775. Prostate Cancer Prostatic Dis. 2005. PMID: 15643451

9

Insulin-like growth factors and risk of benign prostatic hyperplasia.

Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Chokkalingam AP, et al. Among authors: sesterhenn ia. Prostate. 2002 Jul 1;52(2):98-105. doi: 10.1002/pros.10096. Prostate. 2002. PMID: 12111701

10

Prediction of prognosis in untreated stage A2 prostatic carcinoma.

Mohler JL, Partin AW, Epstein JI, Becker RL, Mikel UV, Sesterhenn IA, Mostofi FK, Gleason DF, Sharief Y, Coffey DS. Mohler JL, et al. Among authors: sesterhenn ia. Cancer. 1992 Jan 15;69(2):511-9. doi: 10.1002/1097-0142(19920115)69:2<511::aid-cncr2820690239>3.0.co;2-3. Cancer. 1992. PMID: 1728382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters